American Healthcare REIT (AHR) Financials

$34.95 +0.62 (+1.81%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$34.17 -0.78 (-2.22%)

As of 05/27/2025 07:15 PM Eastern

Annual Income Statements for American Healthcare REIT

This table shows American Healthcare REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	-38	-71	-81	-48
Consolidated Net Income / (Loss)	-36	-77	-73	-53
Net Income / (Loss) Continuing Operations	-36	-77	-73	-53
Total Pre-Tax Income	-34	-76	-73	-52
Total Operating Income	84	47	28	21
Total Gross Profit	417	364	362	252
Total Revenue	2,071	1,867	1,643	1,282
Operating Revenue	2,071	1,867	1,643	1,282
Total Cost of Revenue	1,654	1,502	1,282	1,030
Operating Cost of Revenue	1,654	1,502	1,282	1,030
Total Operating Expenses	333	317	334	231
Selling, General & Admin Expense	48	48	43	43
Depreciation Expense	179	183	168	133
Other Operating Expenses / (Income)	53	57	60	39
Impairment Charge	46	24	78	3.34
Restructuring Charge	7.14	5.80	4.39	13
Other Special Charges / (Income)	0.00	-0.73	-20	0.00
Total Other Income / (Expense), net	-118	-123	-101	-73
Interest Expense	128	163	106	81
Interest & Investment Income	4.49	5.88	4.47	0.50
Other Income / (Expense), net	5.47	34	0.78	7.54
Income Tax Expense	1.71	0.66	0.59	0.96
Net Income / (Loss) Attributable to Noncontrolling Interest	2.21	-5.42	7.92	-5.48
Basic Earnings per Share	($0.29)	($1.08)	($1.24)	($0.95)
Weighted Average Basic Shares Outstanding	130.64M	66.05M	65.81M	50.08M
Diluted Earnings per Share	($0.29)	($1.08)	($1.24)	($0.95)
Weighted Average Diluted Shares Outstanding	130.64M	66.05M	65.81M	50.08M
Weighted Average Basic & Diluted Shares Outstanding	157.57M	65.37M	-	-
Cash Dividends to Common per Share	$1.00	$1.00	$1.60	$0.69

This table shows American Healthcare REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-32	-4.13	1.98	-3.89	-27	-5.99	-12	-26	-	-14
Consolidated Net Income / (Loss)	-32	-3.09	2.93	-3.00	-31	-6.45	-12	-28	-	-7.64
Net Income / (Loss) Continuing Operations	-32	-3.09	2.93	-3.00	-31	-6.45	-12	-28	-	-7.64
Total Pre-Tax Income	-32	-2.83	3.61	-2.73	-31	-6.16	-12	-27	-	-7.52
Total Operating Income	-6.41	34	32	25	14	0.91	23	9.56	-	21
Total Gross Profit	112	107	102	96	98	90	95	82	-	89
Total Revenue	543	524	505	500	483	464	468	452	-	426
Operating Revenue	543	524	505	500	483	464	468	452	-	426
Total Cost of Revenue	431	417	403	404	385	375	373	370	-	337
Operating Cost of Revenue	431	417	403	404	385	375	373	370	-	337
Total Operating Expenses	119	73	70	71	84	89	72	73	-	67
Selling, General & Admin Expense	12	12	12	12	11	11	12	13	-	9.63
Depreciation Expense	47	44	45	43	44	49	45	45	-	40
Other Operating Expenses / (Income)	13	13	13	14	13	15	15	15	-	15
Restructuring Charge	0.81	3.54	0.02	2.78	3.55	1.02	0.89	0.33	-	0.23
Total Other Income / (Expense), net	-26	-37	-28	-28	-45	-7.08	-35	-37	-	-29
Interest Expense	30	30	31	36	41	42	41	39	-	28
Interest & Investment Income	1.74	0.02	2.07	0.66	0.86	1.25	2.48	1.30	-	0.33
Other Income / (Expense), net	3.03	-6.28	0.47	8.25	-4.50	34	3.99	0.68	-	-1.58
Income Tax Expense	0.49	0.26	0.69	0.28	-0.11	0.28	0.35	0.14	-	0.13
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.66	1.03	0.95	0.89	-3.53	-0.46	0.32	-1.74	-	5.86
Basic Earnings per Share	($0.23)	($0.03)	$0.01	($0.04)	($0.41)	($0.09)	($0.19)	($0.39)	-	($0.21)
Weighted Average Basic Shares Outstanding	130.64M	133.73M	130.53M	104.30M	66.05M	66.05M	66.03M	66.03M	65.81M	65.82M
Diluted Earnings per Share	($0.23)	($0.03)	$0.01	($0.04)	($0.41)	($0.09)	($0.19)	($0.39)	-	($0.21)
Weighted Average Diluted Shares Outstanding	130.64M	133.73M	130.69M	104.30M	66.05M	66.05M	66.03M	66.03M	65.81M	65.82M
Weighted Average Basic & Diluted Shares Outstanding	157.57M	153.06M	131.65M	131.65M	65.37M	66.23M	-	-	0.00	-

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Change in Cash & Equivalents	33	-21	-14	-27
Net Cash From Operating Activities	176	99	148	18
Net Cash From Continuing Operating Activities	176	99	148	18
Net Income / (Loss) Continuing Operations	-36	-77	-73	-53
Consolidated Net Income / (Loss)	-36	-77	-73	-53
Depreciation Expense	179	183	168	133
Amortization Expense	42	55	33	24
Non-Cash Adjustments To Reconcile Net Income	60	-7.01	59	-1.32
Changes in Operating Assets and Liabilities, net	-70	-55	-38	-85
Net Cash From Investing Activities	-8.73	9.40	-119	-139
Net Cash From Continuing Investing Activities	-8.73	9.40	-119	-139
Purchase of Property, Plant & Equipment	-152	-145	-145	-80
Acquisitions	-0.24	-13	-19	-1.20
Sale of Property, Plant & Equipment	141	185	48	4.50
Sale and/or Maturity of Investments	30	6.08	0.00	-
Other Investing Activities, net	-28	-23	-3.55	0.00
Net Cash From Financing Activities	-135	-129	-43	94
Net Cash From Continuing Financing Activities	-135	-129	-43	94
Repayment of Debt	-1,953	-566	-1,241	-196
Repurchase of Preferred Equity	-36	-	-	-8.93
Repurchase of Common Equity	-73	-1.96	-23	-0.39
Payment of Dividends	-125	-86	-67	-39
Issuance of Debt	954	562	1,280	350
Issuance of Common Equity	1,364	0.00	0.00	-
Other Financing Activities, net	-267	-36	7.04	-11
Cash Interest Paid	116	153	89	70
Cash Income Taxes Paid	1.32	1.30	1.13	1.24

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	6.73	19	-27	34	8.58	-11	5.51	-24	-13	-
Net Cash From Operating Activities	60	63	59	-5.95	26	29	20	24	34	-
Net Cash From Continuing Operating Activities	60	63	59	-5.95	26	29	20	24	34	-
Net Income / (Loss) Continuing Operations	-32	-3.09	2.93	-3.00	-31	-6.45	-12	-28	-49	-
Consolidated Net Income / (Loss)	-32	-3.09	2.93	-3.00	-31	-6.45	-12	-28	-49	-
Depreciation Expense	47	44	45	43	44	49	45	45	45	-
Amortization Expense	10	9.65	11	12	8.12	14	12	20	11	-
Non-Cash Adjustments To Reconcile Net Income	53	1.54	3.46	1.46	8.73	-16	1.71	-1.37	33	-
Changes in Operating Assets and Liabilities, net	-18	11	-3.09	-59	-4.07	-12	-27	-12	-5.93	-
Net Cash From Investing Activities	87	-30	-60	-5.22	-11	11	43	-33	3.96	-
Net Cash From Continuing Investing Activities	87	-30	-60	-5.22	-11	11	43	-33	3.96	-
Purchase of Property, Plant & Equipment	-38	-30	-65	-20	-25	-55	-31	-33	-18	-
Acquisitions	-0.24	-	-	0.00	-0.59	-	-6.00	-6.34	-0.42	-
Sale of Property, Plant & Equipment	127	0.01	-0.00	15	17	80	81	6.90	23	-
Sale and/or Maturity of Investments	6.45	4.40	11	8.38	6.08	-	-	0.00	-	-
Other Investing Activities, net	-7.82	-5.26	-6.64	-7.89	-8.06	-14	-0.31	-0.71	-0.03	-
Net Cash From Financing Activities	-140	-14	-26	45	-5.89	-52	-57	-14	-51	-
Net Cash From Continuing Financing Activities	-140	-14	-26	45	-5.89	-52	-57	-14	-51	-
Repayment of Debt	-538	-339	-277	-799	-160	-150	-168	-88	-168	-
Repurchase of Common Equity	33	-57	-1.94	-48	15	-16	-0.87	-0.08	-5.88	-
Payment of Dividends	-39	-34	-34	-18	-18	-18	-20	-31	-20	-
Issuance of Debt	325	168	299	163	158	143	139	121	122	-
Issuance of Common Equity	120	471	-	773	-	-	-	0.00	-	-
Other Financing Activities, net	-5.14	-223	-37	-0.73	-1.54	-27	-7.03	-0.88	20	-
Cash Interest Paid	25	28	27	36	39	38	39	37	28	-
Cash Income Taxes Paid	0.43	0.16	0.58	0.16	0.28	0.22	0.41	0.38	0.48	-

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	4,488	4,578	4,787
Total Current Assets	288	229	203
Cash & Equivalents	77	43	65
Accounts Receivable	211	185	138
Plant, Property, & Equipment, net	3,367	3,425	3,582
Total Noncurrent Assets	834	924	1,003
Goodwill	235	235	232
Intangible Assets	161	180	236
Other Noncurrent Operating Assets	437	508	535
Total Liabilities & Shareholders' Equity	4,488	4,578	4,787
Total Liabilities	2,184	3,119	3,137
Total Current Liabilities	258	243	244
Accounts Payable	258	243	244
Total Noncurrent Liabilities	1,926	2,876	2,894
Long-Term Debt	1,671	2,526	2,512
Capital Lease Obligations	165	226	273
Noncurrent Deferred Revenue	52	76	50
Other Noncurrent Operating Liabilities	38	48	59
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.22	34	82
Total Equity & Noncontrolling Interests	2,304	1,425	1,568
Total Preferred & Common Equity	2,261	1,270	1,400
Preferred Stock	0.00	0.00	0.00
Total Common Equity	2,261	1,270	1,400
Common Stock	3,722	2,549	2,541
Retained Earnings	-1,458	-1,276	-1,138
Accumulated Other Comprehensive Income / (Loss)	-2.51	-2.43	-2.69
Noncontrolling Interest	43	155	168

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023
Total Assets	4,677	4,645	4,703	4,589
Total Current Assets	272	253	293	205
Cash & Equivalents	68	52	77	35
Accounts Receivable	204	201	216	169
Plant, Property, & Equipment, net	3,536	3,510	3,479	0.00
Total Noncurrent Assets	870	882	932	4,384
Goodwill	235	235	235	235
Intangible Assets	178	179	188	197
Other Noncurrent Operating Assets	457	468	509	3,952
Total Liabilities & Shareholders' Equity	4,677	4,645	4,703	4,589
Total Liabilities	2,420	2,541	2,561	3,055
Total Current Liabilities	270	254	257	234
Accounts Payable	270	254	257	234
Total Noncurrent Liabilities	2,150	2,287	2,303	2,821
Long-Term Debt	1,879	2,012	1,988	2,498
Capital Lease Obligations	174	179	220	-
Noncurrent Deferred Revenue	52	50	49	44
Other Noncurrent Operating Liabilities	45	46	47	279
Commitments & Contingencies	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.22	0.22	12	60
Total Equity & Noncontrolling Interests	2,257	2,104	2,131	1,474
Total Preferred & Common Equity	2,207	1,933	1,961	1,314
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	2,207	1,933	1,961	1,314
Common Stock	3,596	3,280	3,277	2,549
Retained Earnings	-1,387	-1,344	-1,313	-1,232
Accumulated Other Comprehensive Income / (Loss)	-2.15	-2.46	-2.47	-2.62
Noncontrolling Interest	49	171	170	159

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Growth Metrics	-	-	-	-
Revenue Growth	10.93%	13.60%	28.15%	0.00%
EBITDA Growth	-2.32%	38.86%	23.60%	0.00%
EBIT Growth	10.20%	182.64%	2.00%	0.00%
NOPAT Growth	77.61%	69.21%	35.57%	0.00%
Net Income Growth	53.70%	-4.77%	-37.76%	0.00%
EPS Growth	73.15%	12.90%	-30.53%	0.00%
Operating Cash Flow Growth	78.71%	-33.32%	724.92%	0.00%
Free Cash Flow Firm Growth	-30.48%	105.39%	0.00%	0.00%
Invested Capital Growth	-2.50%	-4.61%	0.00%	0.00%
Revenue Q/Q Growth	2.99%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-2.40%	31.68%	0.00%	0.00%
EBIT Q/Q Growth	-12.39%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	-19.38%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-4.31%	0.00%	0.00%	0.00%
EPS Q/Q Growth	38.30%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	23.70%	-7.99%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	194.38%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-4.22%	4.27%	0.00%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	20.13%	19.52%	22.01%	19.66%
EBITDA Margin	15.02%	17.06%	13.95%	14.47%
Operating Margin	4.05%	2.53%	1.70%	1.61%
EBIT Margin	4.32%	4.34%	1.75%	2.19%
Profit (Net Income) Margin	-1.72%	-4.12%	-4.47%	-4.15%
Tax Burden Percent	105.06%	100.87%	100.81%	101.83%
Interest Burden Percent	-37.92%	-94.01%	-253.75%	-186.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	1.43%	0.77%	0.89%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.80%	-3.28%	-5.94%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-3.32%	-5.72%	-9.79%	0.00%
Return on Equity (ROE)	-1.89%	-4.95%	-8.90%	0.00%
Cash Return on Invested Capital (CROIC)	3.96%	5.49%	-199.11%	0.00%
Operating Return on Assets (OROA)	1.97%	1.73%	1.20%	0.00%
Return on Assets (ROA)	-0.79%	-1.64%	-3.07%	0.00%
Return on Common Equity (ROCE)	-1.78%	-4.25%	-7.55%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-1.57%	-6.05%	-5.24%	0.00%
Net Operating Profit after Tax (NOPAT)	59	33	20	14
NOPAT Margin	2.84%	1.77%	1.19%	1.12%
Net Nonoperating Expense Percent (NNEP)	4.22%	4.05%	6.83%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.42%	0.79%	0.45%	-
Cost of Revenue to Revenue	79.87%	80.48%	77.99%	80.34%
SG&A Expenses to Revenue	2.30%	2.55%	2.64%	3.37%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	16.08%	16.99%	20.31%	18.05%
Earnings before Interest and Taxes (EBIT)	89	81	29	28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	311	318	229	186
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	1.92	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	2.33	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.10	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	3.52%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.51	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.97	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	19.78	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	68.85	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	104.77	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	34.94	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	37.74	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.80	1.89	1.69	0.00
Long-Term Debt to Equity	0.80	1.89	1.69	0.00
Financial Leverage	1.19	1.75	1.65	0.00
Leverage Ratio	2.41	3.01	2.90	0.00
Compound Leverage Factor	-0.91	-2.83	-7.36	0.00
Debt to Total Capital	44.34%	65.35%	62.80%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	44.34%	65.35%	62.80%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.04%	4.48%	5.62%	0.00%
Common Equity to Total Capital	54.62%	30.17%	31.58%	0.00%
Debt to EBITDA	5.90	8.64	12.15	0.00
Net Debt to EBITDA	5.66	8.51	11.86	0.00
Long-Term Debt to EBITDA	5.90	8.64	12.15	0.00
Debt to NOPAT	31.26	83.23	142.52	0.00
Net Debt to NOPAT	29.96	81.92	139.19	0.00
Long-Term Debt to NOPAT	31.26	83.23	142.52	0.00
Altman Z-Score	1.28	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	6.16%	14.09%	15.11%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	1.11	0.94	0.83	0.00
Quick Ratio	1.11	0.94	0.83	0.00
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	163	234	-4,349	0.00
Operating Cash Flow to CapEx	1,597.89%	0.00%	153.20%	23.82%
Free Cash Flow to Firm to Interest Expense	1.28	1.44	-41.05	0.00
Operating Cash Flow to Interest Expense	1.38	0.60	1.39	0.22
Operating Cash Flow Less CapEx to Interest Expense	1.29	0.85	0.48	-0.71
Efficiency Ratios	-	-	-	-
Asset Turnover	0.46	0.40	0.69	0.00
Accounts Receivable Turnover	10.45	11.56	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.61	0.53	0.00	0.00
Accounts Payable Turnover	6.60	6.17	0.00	0.00
Days Sales Outstanding (DSO)	34.94	31.57	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	55.31	59.13	0.00	0.00
Cash Conversion Cycle (CCC)	-20.36	-27.56	0.00	0.00
Capital & Investment Metrics	-	-	-	-
Invested Capital	4,063	4,168	4,369	0.00
Invested Capital Turnover	0.50	0.44	0.75	0.00
Increase / (Decrease) in Invested Capital	-104	-201	4,369	0.00
Enterprise Value (EV)	6,152	0.00	0.00	0.00
Market Capitalization	4,350	0.00	0.00	0.00
Book Value per Share	$14.77	$19.18	$21.28	$0.00
Tangible Book Value per Share	$12.18	$12.91	$14.17	$0.00
Total Capital	4,140	4,211	4,434	0.00
Total Debt	1,836	2,752	2,785	0.00
Total Long-Term Debt	1,836	2,752	2,785	0.00
Net Debt	1,759	2,708	2,720	0.00
Capital Expenditures (CapEx)	11	-39	96	75
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-47	-58	-106	0.00
Debt-free Net Working Capital (DFNWC)	29	-14	-41	0.00
Net Working Capital (NWC)	29	-14	-41	0.00
Net Nonoperating Expense (NNE)	94	110	93	68
Net Nonoperating Obligations (NNO)	1,759	2,708	2,720	0.00
Total Depreciation and Amortization (D&A)	222	237	201	157
Debt-free, Cash-free Net Working Capital to Revenue	-2.28%	-3.08%	-6.47%	0.00%
Debt-free Net Working Capital to Revenue	1.42%	-0.75%	-2.51%	0.00%
Net Working Capital to Revenue	1.42%	-0.75%	-2.51%	0.00%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($0.29)	($1.08)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	130.64M	66.05M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.29)	($1.08)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	130.64M	66.05M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	157.57M	65.37M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	96	54	63	26
Normalized NOPAT Margin	4.62%	2.88%	3.86%	2.02%
Pre Tax Income Margin	-1.64%	-4.08%	-4.43%	-4.08%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.70	0.50	0.27	0.35
NOPAT to Interest Expense	0.46	0.20	0.18	0.18
EBIT Less CapEx to Interest Expense	0.61	0.74	-0.64	-0.58
NOPAT Less CapEx to Interest Expense	0.37	0.44	-0.73	-0.75
Payout Ratios	-	-	-	-
Dividend Payout Ratio	-349.76%	-112.36%	-91.29%	-73.49%
Augmented Payout Ratio	-554.07%	-114.90%	-122.34%	-74.22%

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.47%	12.83%	7.92%	10.46%	0.00%	8.94%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	-12.48%	-16.71%	5.09%	16.40%	8.43%	62.72%	0.00%	0.00%	0.00%	0.00%
EBIT Growth	-136.54%	-20.36%	19.05%	222.89%	0.00%	75.78%	0.00%	0.00%	0.00%	0.00%
NOPAT Growth	-146.62%	3,601.53%	59.30%	159.52%	0.00%	-95.70%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	-4.75%	52.02%	124.66%	89.12%	0.00%	15.67%	0.00%	0.00%	0.00%	0.00%
EPS Growth	43.90%	66.67%	105.26%	89.74%	0.00%	57.14%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	130.93%	116.76%	200.31%	-124.95%	-24.93%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	-52.71%	94.45%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	-2.50%	6.14%	0.00%	0.00%	-4.61%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	3.61%	3.81%	1.01%	3.51%	3.95%	-0.71%	3.39%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-34.10%	-7.70%	0.72%	42.85%	-37.28%	16.46%	11.55%	33.07%	-5.88%	0.00%
EBIT Q/Q Growth	-112.28%	-14.27%	-2.77%	256.99%	-73.23%	28.15%	163.70%	0.00%	-100.00%	0.00%
NOPAT Q/Q Growth	-118.95%	-7.69%	47.78%	80.30%	1,404.92%	-96.03%	140.75%	0.00%	-100.00%	0.00%
Net Income Q/Q Growth	-948.46%	-205.71%	197.40%	90.30%	-380.28%	45.68%	57.03%	0.00%	0.00%	0.00%
EPS Q/Q Growth	-666.67%	-400.00%	125.00%	90.24%	-355.56%	52.63%	51.28%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-5.74%	6.28%	1,097.68%	-123.11%	-11.52%	47.24%	-17.11%	-30.49%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	144.98%	94.74%	0.90%	-2,116.48%	105.28%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-4.22%	-0.02%	-0.71%	2.54%	4.27%	0.00%	0.00%	-100.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.67%	20.37%	20.22%	19.20%	20.22%	19.31%	20.32%	18.15%	0.00%	20.81%
EBITDA Margin	9.89%	15.55%	17.49%	17.54%	12.71%	21.07%	17.96%	16.65%	0.00%	14.10%
Operating Margin	-1.18%	6.46%	6.28%	4.96%	2.85%	0.20%	4.92%	2.11%	0.00%	4.99%
EBIT Margin	-0.62%	5.26%	6.37%	6.62%	1.92%	7.45%	5.77%	2.26%	0.00%	4.62%
Profit (Net Income) Margin	-5.98%	-0.59%	0.58%	-0.60%	-6.42%	-1.39%	-2.54%	-6.11%	0.00%	-1.79%
Tax Burden Percent	101.52%	109.29%	81.01%	110.20%	99.64%	104.61%	103.02%	100.52%	0.00%	101.68%
Interest Burden Percent	944.22%	-10.27%	11.24%	-8.25%	-335.58%	-17.81%	-42.67%	-268.36%	0.00%	-38.20%
Effective Tax Rate	0.00%	0.00%	18.99%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-0.42%	2.21%	4.68%	3.11%	0.87%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.67%	1.00%	2.55%	1.20%	-0.62%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-1.98%	1.18%	2.59%	1.19%	-1.09%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-2.39%	3.38%	7.27%	4.31%	-0.22%	0.00%	0.00%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	3.96%	-4.19%	-197.65%	-197.95%	5.49%	0.00%	0.00%	0.00%	-99.55%	0.00%
Operating Return on Assets (OROA)	-0.28%	2.28%	5.35%	5.39%	0.76%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	-2.73%	-0.26%	0.49%	-0.49%	-2.56%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-2.25%	3.14%	6.68%	3.94%	-0.18%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-1.55%	-1.94%	-2.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.49	24	26	17	9.63	0.64	16	6.69	0.00	15
NOPAT Margin	-0.83%	4.52%	5.08%	3.48%	2.00%	0.14%	3.44%	1.48%	0.00%	3.49%
Net Nonoperating Expense Percent (NNEP)	1.25%	1.20%	2.13%	1.91%	1.50%	0.58%	0.00%	0.00%	0.00%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-0.11%	-	-	-	0.23%	-	-	-	0.00%	-
Cost of Revenue to Revenue	79.33%	79.63%	79.78%	80.80%	79.78%	80.69%	79.68%	81.85%	0.00%	79.19%
SG&A Expenses to Revenue	2.22%	2.28%	2.33%	2.37%	2.35%	2.44%	2.52%	2.89%	0.00%	2.26%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.85%	13.91%	13.94%	14.23%	17.37%	19.11%	15.40%	16.04%	0.00%	15.82%
Earnings before Interest and Taxes (EBIT)	-3.38	28	32	33	9.26	35	27	10	0.00	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	54	81	88	88	61	98	84	75	57	60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.92	1.56	0.99	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	2.33	1.91	1.27	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.10	1.71	0.99	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	3.52%	2.87%	3.42%	1.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.29	1.00	0.76	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.97	2.72	2.17	1.70	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	19.78	17.17	12.64	9.86	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	68.85	53.64	38.82	31.38	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	104.77	75.11	85.01	74.55	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	34.94	38.43	39.07	47.45	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	37.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.80	0.91	1.04	1.03	1.89	1.63	0.00	0.00	1.69	0.00
Long-Term Debt to Equity	0.80	0.91	1.04	1.03	1.89	1.63	0.00	0.00	1.69	0.00
Financial Leverage	1.19	1.17	1.02	0.99	1.75	1.61	0.00	0.00	1.65	0.00
Leverage Ratio	2.41	2.44	2.21	2.20	3.01	2.99	0.00	0.00	2.90	0.00
Compound Leverage Factor	22.75	-0.25	0.25	-0.18	-10.11	-0.53	0.00	0.00	0.00	0.00
Debt to Total Capital	44.34%	47.63%	51.01%	50.74%	65.35%	61.96%	0.00%	0.00%	62.80%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	44.34%	47.63%	51.01%	50.74%	65.35%	61.96%	0.00%	0.00%	62.80%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.04%	1.15%	3.98%	4.18%	4.48%	5.44%	0.00%	0.00%	5.62%	0.00%
Common Equity to Total Capital	54.62%	51.22%	45.01%	45.07%	30.17%	32.60%	0.00%	0.00%	31.58%	0.00%
Debt to EBITDA	5.90	6.44	6.54	6.67	8.64	10.33	0.00	0.00	12.15	0.00
Net Debt to EBITDA	5.66	6.23	6.39	6.44	8.51	10.19	0.00	0.00	11.86	0.00
Long-Term Debt to EBITDA	5.90	6.44	6.54	6.67	8.64	10.33	0.00	0.00	12.15	0.00
Debt to NOPAT	31.26	28.19	44.00	50.48	83.23	0.00	0.00	0.00	142.52	0.00
Net Debt to NOPAT	29.96	27.25	42.95	48.72	81.92	0.00	0.00	0.00	139.19	0.00
Long-Term Debt to NOPAT	31.26	28.19	44.00	50.48	83.23	0.00	0.00	0.00	142.52	0.00
Altman Z-Score	1.21	0.89	0.49	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	6.16%	7.10%	8.11%	8.49%	14.09%	14.31%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.11	1.01	1.00	1.14	0.94	0.87	0.00	0.00	0.83	0.00
Quick Ratio	1.11	1.01	1.00	1.14	0.94	0.87	0.00	0.00	0.83	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	100	-222	-4,217	-4,256	211	-3,996	0.00	0.00	0.00	0.00
Operating Cash Flow to CapEx	0.00%	213.63%	92.00%	-104.16%	295.04%	0.00%	0.00%	90.80%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	3.29	-7.30	-137.84	-116.80	5.12	-95.14	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	1.96	2.08	1.94	-0.16	0.63	0.69	0.48	0.61	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	4.90	1.10	-0.17	-0.32	0.41	1.29	1.69	-0.06	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.43	0.84	0.81	0.40	0.00	0.00	0.00	0.69	0.00
Accounts Receivable Turnover	10.45	10.78	0.00	0.00	11.56	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.61	0.00	0.00	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	6.60	6.39	0.00	0.00	6.17	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	34.94	33.87	0.00	0.00	31.57	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	55.31	57.16	0.00	0.00	59.13	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	-20.36	-23.28	0.00	0.00	-27.56	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,063	4,242	4,243	4,273	4,168	3,997	0.00	0.00	4,369	0.00
Invested Capital Turnover	0.50	0.49	0.92	0.90	0.44	0.00	0.00	0.00	0.38	0.00
Increase / (Decrease) in Invested Capital	-104	246	4,243	4,273	-201	3,997	0.00	0.00	0.00	0.00
Enterprise Value (EV)	6,152	5,471	4,233	3,260	0.00	0.00	0.00	0.00	0.00	0.00
Market Capitalization	4,350	3,436	1,923	948	0.00	0.00	0.00	0.00	0.00	0.00
Book Value per Share	$14.77	$16.77	$14.69	$30.00	$19.18	$19.90	$0.00	$0.00	$21.28	$0.00
Tangible Book Value per Share	$12.18	$13.63	$11.54	$23.53	$12.91	$13.36	$0.00	$0.00	$14.17	$0.00
Total Capital	4,140	4,310	4,295	4,350	4,211	4,032	0.00	0.00	4,434	0.00
Total Debt	1,836	2,053	2,191	2,208	2,752	2,498	0.00	0.00	2,785	0.00
Total Long-Term Debt	1,836	2,053	2,191	2,208	2,752	2,498	0.00	0.00	2,785	0.00
Net Debt	1,759	1,985	2,139	2,130	2,708	2,463	0.00	0.00	2,720	0.00
Capital Expenditures (CapEx)	-89	30	65	5.72	8.73	-25	-49	26	-4.41	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-47	-66	-53	-41	-58	-64	0.00	0.00	-106	0.00
Debt-free Net Working Capital (DFNWC)	29	1.74	-0.54	36	-14	-29	0.00	0.00	-41	0.00
Net Working Capital (NWC)	29	1.74	-0.54	36	-14	-29	0.00	0.00	-41	0.00
Net Nonoperating Expense (NNE)	28	27	23	20	41	7.09	28	34	0.00	23
Net Nonoperating Obligations (NNO)	1,759	1,985	2,139	2,130	2,708	2,463	0.00	0.00	2,720	0.00
Total Depreciation and Amortization (D&A)	57	54	56	55	52	63	57	65	57	40
Debt-free, Cash-free Net Working Capital to Revenue	-2.28%	-3.29%	-2.70%	-2.16%	-3.08%	0.00%	0.00%	0.00%	-6.47%	0.00%
Debt-free Net Working Capital to Revenue	1.42%	0.09%	-0.03%	1.86%	-0.75%	0.00%	0.00%	0.00%	-2.51%	0.00%
Net Working Capital to Revenue	1.42%	0.09%	-0.03%	1.86%	-0.75%	0.00%	0.00%	0.00%	-2.51%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.23)	($0.03)	$0.01	($0.04)	($0.41)	($0.09)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	130.64M	133.73M	130.53M	104.30M	66.05M	66.05M	0.00	0.00	65.81M	0.00
Adjusted Diluted Earnings per Share	($0.23)	($0.03)	$0.01	($0.04)	($0.41)	($0.09)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	130.64M	133.73M	130.69M	104.30M	66.05M	66.05M	0.00	0.00	65.81M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	157.57M	153.06M	131.65M	131.65M	65.37M	66.23M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-3.92	26	26	19	12	10	17	6.41	0.00	17
Normalized NOPAT Margin	-0.72%	4.99%	5.09%	3.87%	2.51%	2.18%	3.58%	1.42%	0.00%	3.91%
Pre Tax Income Margin	-5.89%	-0.54%	0.72%	-0.55%	-6.44%	-1.33%	-2.46%	-6.07%	0.00%	-1.76%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.11	0.91	1.05	0.91	0.22	0.82	0.66	0.26	0.00	0.72
NOPAT to Interest Expense	-0.15	0.78	0.84	0.48	0.23	0.02	0.39	0.17	0.00	0.54
EBIT Less CapEx to Interest Expense	2.82	-0.07	-1.06	0.75	0.01	1.42	1.86	-0.41	0.00	0.72
NOPAT Less CapEx to Interest Expense	2.78	-0.19	-1.27	0.32	0.02	0.61	1.60	-0.50	0.00	0.54
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-349.76%	-303.75%	-232.75%	-140.42%	-112.36%	0.00%	0.00%	0.00%	-91.29%	0.00%
Augmented Payout Ratio	-554.07%	-570.25%	-367.46%	-234.96%	-114.90%	0.00%	0.00%	0.00%	-122.34%	0.00%

Frequently Asked Questions About American Healthcare REIT's Financials

When does American Healthcare REIT's fiscal year end?

According to the most recent income statement we have on file, American Healthcare REIT's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has American Healthcare REIT's net income changed over the last 3 years?

American Healthcare REIT's net income appears to be on a downward trend, with a most recent value of -$35.60 million in 2024, falling from -$53.27 million in 2021. The previous period was -$76.89 million in 2023. View American Healthcare REIT's forecast to see where analysts expect American Healthcare REIT to go next.

What is American Healthcare REIT's operating income?

American Healthcare REIT's total operating income in 2024 was $83.89 million, based on the following breakdown:

Total Gross Profit: $416.78 million
Total Operating Expenses: $332.89 million

How has American Healthcare REIT revenue changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's total revenue changed from $1.28 billion in 2021 to $2.07 billion in 2024, a change of 61.5%.

How much debt does American Healthcare REIT have?

American Healthcare REIT's total liabilities were at $2.18 billion at the end of 2024, a 30.0% decrease from 2023, and a 30.4% decrease since 2022.

How much cash does American Healthcare REIT have?

In the past 2 years, American Healthcare REIT's cash and equivalents has ranged from $43.45 million in 2023 to $76.70 million in 2024, and is currently $76.70 million as of their latest financial filing in 2024.

How has American Healthcare REIT's book value per share changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's book value per share changed from 0.00 in 2021 to 14.77 in 2024, a change of 1,477.3%.

Related Companies

This page (NYSE:AHR) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Healthcare REIT (AHR) Financials

Frequently Asked Questions About American Healthcare REIT's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Healthcare REIT (AHR) Financials

Annual Income Statements for American Healthcare REIT

Quarterly Income Statements for American Healthcare REIT

Annual Cash Flow Statements for American Healthcare REIT

Quarterly Cash Flow Statements for American Healthcare REIT

Annual Balance Sheets for American Healthcare REIT

Quarterly Balance Sheets for American Healthcare REIT

Annual Metrics And Ratios for American Healthcare REIT

Quarterly Metrics And Ratios for American Healthcare REIT

Frequently Asked Questions About American Healthcare REIT's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools